Truvian latest medtech firm to receive large venture backing

By William Smith
Share
Truvian's offering is designed around removing the need to send blood for testing at centralised labs, instead allowing clinicians to do check-ups on si...

San Diego, California-based Truvian is a medtech firm using automation to provide blood-testing diagnostics.

The company’s offering is designed around removing the need to send blood for testing at centralised labs, instead allowing clinicians to do check-ups on site, saving both time and money.

A holistic solution

Currently still in development, Truvian’s benchtop system is able to carry out a range of blood tests in one device, including chemistries, immunoassays, and hematology assays.

Since its 2015 foundation, the company has raised over $150mn including in three funding rounds. Its most significant round to date came yesterday, via a $105mn Series C. Led by TYH Ventures, 7WireVentures and Wittington Ventures, the round also involved General Catalyst, GreatPoint Ventures, DNS Capital, and Wasson Enterprise.

"The global pandemic has further demonstrated that consumers want more control over their personal healthcare journeys. Today's announcement signifies tremendous confidence in Truvian's goal of decentralizing healthcare by bringing point-of-care diagnostic testing to a highly complex, distributed market," said Jeff Hawkins, President and Chief Executive Officer of Truvian. "I have full confidence that our executive team and board have the proven leadership and depth of experience in healthcare to deliver our benchtop platform and test menu through global regulatory approvals, making routine testing more convenient and accessible for all."

Consumer-directed healthcare

The company said it would use the funds to continue development before submitting it for US Food and Drug Administration (FDA) clearance.

"As we move to a more consumer-directed system of healthcare, providing easy, convenient access to a full suite of high-quality blood tests at a local pharmacy, an on-site clinic at work or a physician office will be a game changer," said Glen Tullman, Managing Partner at 7wireVentures. "New rapid diagnostic tools are essential to provide health consumers with more information earlier in the process and equip clinicians with the information they need to provide high-quality care."

Share

Featured Articles

How Quantum Computing Could Add £212bn to UK Economy by 2045

Oxford Economics research shows quantum technology could increase UK productivity by 7% by 2045, with pharmaceutical and defence sectors leading adoption

Why UK’s MoD is Investing £50m in AI and Data Analytics

Kainos has secured a £50m agreement to enhance the UK Ministry of Defence’s Defence Data Analytics Platform, supporting Royal Navy, Army and RAF operations

SAP: Why The UK Faces AI Adoption Hurdles Amid Global Race

SAP reports on the UK’s AI position as businesses worldwide grapple with infrastructure limitations, talent shortages and data quality issues

Quantinuum: The First Quantum-Generated Data For AI

AI & Machine Learning

How Can The UK Support its AI and Creative Tech Startups?

AI & Machine Learning

What do Nvidia’s New AI Features Mean For The Tech Industry?

AI & Machine Learning